| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epithelial Sodium Channels | 16 | 2022 | 25 | 3.800 |
Why?
|
| Podocytes | 10 | 2022 | 113 | 3.770 |
Why?
|
| Kidney Glomerulus | 12 | 2022 | 155 | 3.300 |
Why?
|
| Kidney Tubules, Collecting | 11 | 2022 | 46 | 3.100 |
Why?
|
| Kidney | 17 | 2022 | 945 | 2.840 |
Why?
|
| TRPC Cation Channels | 7 | 2018 | 10 | 2.710 |
Why?
|
| Diabetic Nephropathies | 7 | 2022 | 161 | 2.120 |
Why?
|
| Calcium | 10 | 2018 | 929 | 1.980 |
Why?
|
| Polycystic Kidney, Autosomal Recessive | 5 | 2021 | 7 | 1.880 |
Why?
|
| Kidney Diseases | 6 | 2020 | 307 | 1.860 |
Why?
|
| Aminobutyrates | 2 | 2021 | 94 | 1.440 |
Why?
|
| Angiotensin II | 7 | 2018 | 220 | 1.380 |
Why?
|
| Sodium | 12 | 2022 | 161 | 1.380 |
Why?
|
| Hypertension | 10 | 2022 | 1535 | 1.330 |
Why?
|
| Animals | 52 | 2022 | 20881 | 1.310 |
Why?
|
| Mitochondria | 4 | 2022 | 643 | 1.270 |
Why?
|
| Myocardial Infarction | 4 | 2021 | 807 | 1.140 |
Why?
|
| Rats | 23 | 2022 | 5300 | 1.070 |
Why?
|
| Rats, Inbred Dahl | 14 | 2022 | 48 | 1.050 |
Why?
|
| TRPC6 Cation Channel | 4 | 2018 | 4 | 0.990 |
Why?
|
| Energy Metabolism | 3 | 2021 | 222 | 0.970 |
Why?
|
| Biphenyl Compounds | 2 | 2021 | 184 | 0.920 |
Why?
|
| Patch-Clamp Techniques | 9 | 2017 | 204 | 0.900 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 2 | 2021 | 25 | 0.890 |
Why?
|
| Signal Transduction | 14 | 2021 | 2689 | 0.860 |
Why?
|
| Actin-Related Protein 2-3 Complex | 2 | 2013 | 3 | 0.840 |
Why?
|
| Cysts | 3 | 2019 | 70 | 0.820 |
Why?
|
| NADPH Oxidase 4 | 2 | 2020 | 17 | 0.810 |
Why?
|
| Nephritis | 2 | 2021 | 37 | 0.800 |
Why?
|
| Cell-Free Nucleic Acids | 2 | 2020 | 11 | 0.800 |
Why?
|
| Membrane Transport Proteins | 2 | 2021 | 81 | 0.800 |
Why?
|
| Immunity, Innate | 2 | 2019 | 156 | 0.790 |
Why?
|
| Water-Electrolyte Balance | 1 | 2021 | 43 | 0.790 |
Why?
|
| Neprilysin | 1 | 2021 | 55 | 0.780 |
Why?
|
| Blood Pressure | 7 | 2022 | 1451 | 0.780 |
Why?
|
| Histamine | 1 | 2021 | 52 | 0.760 |
Why?
|
| Insulin | 3 | 2015 | 619 | 0.750 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2021 | 266 | 0.750 |
Why?
|
| Renal Insufficiency | 1 | 2021 | 121 | 0.730 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2020 | 52 | 0.720 |
Why?
|
| Nephrology | 1 | 2020 | 43 | 0.720 |
Why?
|
| Valsartan | 1 | 2020 | 99 | 0.700 |
Why?
|
| Natriuretic Peptides | 1 | 2019 | 12 | 0.680 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 37 | 0.680 |
Why?
|
| Diet, Sodium-Restricted | 2 | 2019 | 45 | 0.680 |
Why?
|
| Tetrazoles | 1 | 2020 | 160 | 0.670 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2020 | 155 | 0.670 |
Why?
|
| Inflammation | 3 | 2021 | 1030 | 0.660 |
Why?
|
| Sodium Chloride, Dietary | 9 | 2022 | 50 | 0.660 |
Why?
|
| Epidermal Growth Factor | 3 | 2013 | 95 | 0.630 |
Why?
|
| Reactive Oxygen Species | 3 | 2018 | 499 | 0.630 |
Why?
|
| Nephrons | 4 | 2022 | 17 | 0.610 |
Why?
|
| Research Design | 1 | 2022 | 729 | 0.610 |
Why?
|
| Adenosine Triphosphate | 2 | 2016 | 314 | 0.600 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 2 | 2015 | 43 | 0.590 |
Why?
|
| Biomedical Research | 1 | 2020 | 310 | 0.570 |
Why?
|
| Mice | 16 | 2022 | 8474 | 0.570 |
Why?
|
| Myocardium | 2 | 2021 | 1204 | 0.570 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2016 | 10 | 0.560 |
Why?
|
| Vasoconstrictor Agents | 1 | 2017 | 107 | 0.550 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2016 | 39 | 0.550 |
Why?
|
| Disease Models, Animal | 11 | 2021 | 2550 | 0.530 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2015 | 110 | 0.520 |
Why?
|
| Cardiovascular Diseases | 2 | 2020 | 940 | 0.510 |
Why?
|
| Calcium Channels | 1 | 2015 | 59 | 0.500 |
Why?
|
| Actins | 2 | 2013 | 249 | 0.490 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2015 | 42 | 0.490 |
Why?
|
| Rats, Sprague-Dawley | 10 | 2018 | 2083 | 0.490 |
Why?
|
| Purinergic P2 Receptor Agonists | 1 | 2013 | 2 | 0.460 |
Why?
|
| Receptors, Purinergic P2Y1 | 1 | 2013 | 3 | 0.460 |
Why?
|
| Purinergic P2 Receptor Antagonists | 1 | 2013 | 10 | 0.460 |
Why?
|
| Actin Cytoskeleton | 1 | 2013 | 37 | 0.440 |
Why?
|
| Dissection | 1 | 2013 | 29 | 0.430 |
Why?
|
| Male | 21 | 2022 | 37321 | 0.410 |
Why?
|
| Atrial Natriuretic Factor | 2 | 2022 | 54 | 0.400 |
Why?
|
| Cortactin | 1 | 2011 | 3 | 0.390 |
Why?
|
| Ion Transport | 3 | 2021 | 26 | 0.370 |
Why?
|
| Mutation | 4 | 2021 | 1213 | 0.370 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 240 | 0.330 |
Why?
|
| Cell Line | 5 | 2019 | 1752 | 0.320 |
Why?
|
| Cricetulus | 6 | 2014 | 98 | 0.300 |
Why?
|
| CHO Cells | 6 | 2014 | 161 | 0.300 |
Why?
|
| Hydrogen Peroxide | 3 | 2018 | 168 | 0.290 |
Why?
|
| Disease Progression | 5 | 2019 | 1038 | 0.290 |
Why?
|
| Humans | 17 | 2022 | 68618 | 0.280 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 2791 | 0.270 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2018 | 195 | 0.270 |
Why?
|
| Mice, Knockout | 4 | 2021 | 1692 | 0.260 |
Why?
|
| Biomarkers | 3 | 2020 | 1593 | 0.240 |
Why?
|
| Receptor, Insulin | 2 | 2015 | 71 | 0.230 |
Why?
|
| TRPP Cation Channels | 2 | 2021 | 20 | 0.220 |
Why?
|
| rac1 GTP-Binding Protein | 3 | 2012 | 23 | 0.220 |
Why?
|
| Indoles | 3 | 2013 | 146 | 0.220 |
Why?
|
| Receptors, Histamine | 1 | 2022 | 3 | 0.200 |
Why?
|
| Albuminuria | 3 | 2019 | 171 | 0.200 |
Why?
|
| Endothelin-1 | 2 | 2015 | 122 | 0.200 |
Why?
|
| Inflammation Mediators | 2 | 2021 | 244 | 0.190 |
Why?
|
| Porphyromonas gingivalis | 1 | 2021 | 33 | 0.190 |
Why?
|
| Immunologic Memory | 1 | 2021 | 75 | 0.190 |
Why?
|
| Periodontitis | 1 | 2021 | 47 | 0.190 |
Why?
|
| Fibroblast Growth Factors | 1 | 2021 | 51 | 0.190 |
Why?
|
| Kidney Function Tests | 2 | 2019 | 114 | 0.190 |
Why?
|
| Fibrosis | 2 | 2020 | 371 | 0.190 |
Why?
|
| Cricetinae | 5 | 2011 | 262 | 0.180 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 248 | 0.180 |
Why?
|
| Immunity | 1 | 2020 | 67 | 0.180 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2020 | 81 | 0.180 |
Why?
|
| Lymphocyte Activation | 1 | 2021 | 397 | 0.170 |
Why?
|
| Nitric Oxide | 2 | 2022 | 382 | 0.170 |
Why?
|
| Heart Rupture, Post-Infarction | 1 | 2019 | 7 | 0.170 |
Why?
|
| CD8 Antigens | 1 | 2019 | 25 | 0.170 |
Why?
|
| Wound Healing | 1 | 2021 | 260 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2021 | 1745 | 0.170 |
Why?
|
| Drug Combinations | 1 | 2020 | 304 | 0.170 |
Why?
|
| Lipopolysaccharides | 1 | 2021 | 455 | 0.170 |
Why?
|
| Mice, Mutant Strains | 1 | 2019 | 166 | 0.170 |
Why?
|
| Receptor, Angiotensin, Type 1 | 3 | 2014 | 80 | 0.170 |
Why?
|
| Aldosterone | 3 | 2016 | 51 | 0.160 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2018 | 4 | 0.160 |
Why?
|
| Receptors, Purinergic P2X4 | 1 | 2018 | 3 | 0.160 |
Why?
|
| Receptors, Purinergic | 1 | 2018 | 10 | 0.160 |
Why?
|
| Histocytochemistry | 1 | 2019 | 149 | 0.160 |
Why?
|
| Kidney Tubules | 1 | 2019 | 80 | 0.160 |
Why?
|
| Immunohistochemistry | 4 | 2014 | 1174 | 0.160 |
Why?
|
| Sex Characteristics | 1 | 2020 | 295 | 0.160 |
Why?
|
| Vesicular Transport Proteins | 1 | 2019 | 87 | 0.160 |
Why?
|
| Homeostasis | 1 | 2019 | 291 | 0.150 |
Why?
|
| Biological Transport | 2 | 2016 | 210 | 0.150 |
Why?
|
| Aging | 2 | 2021 | 911 | 0.150 |
Why?
|
| Cilia | 1 | 2019 | 94 | 0.150 |
Why?
|
| RNA Interference | 1 | 2019 | 266 | 0.150 |
Why?
|
| Kidney Tubules, Distal | 1 | 2017 | 15 | 0.150 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2017 | 16 | 0.150 |
Why?
|
| Biology | 1 | 2017 | 14 | 0.150 |
Why?
|
| Sodium Chloride | 1 | 2017 | 136 | 0.150 |
Why?
|
| Calcium Signaling | 1 | 2017 | 97 | 0.140 |
Why?
|
| Sex Factors | 1 | 2020 | 1266 | 0.140 |
Why?
|
| Congresses as Topic | 1 | 2017 | 85 | 0.140 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 2077 | 0.140 |
Why?
|
| Receptor, PAR-1 | 1 | 2016 | 30 | 0.140 |
Why?
|
| Leucine | 1 | 2016 | 41 | 0.140 |
Why?
|
| Cathepsins | 1 | 2016 | 37 | 0.140 |
Why?
|
| Ventricular Remodeling | 1 | 2019 | 318 | 0.140 |
Why?
|
| Renin | 1 | 2016 | 96 | 0.140 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2016 | 73 | 0.130 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 337 | 0.130 |
Why?
|
| Collagen | 1 | 2019 | 636 | 0.130 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 1033 | 0.130 |
Why?
|
| Renal Artery | 1 | 2015 | 29 | 0.130 |
Why?
|
| Research | 1 | 2017 | 214 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2020 | 529 | 0.130 |
Why?
|
| Perfusion | 2 | 2013 | 131 | 0.130 |
Why?
|
| Liver | 1 | 2021 | 1118 | 0.130 |
Why?
|
| Amiloride | 4 | 2017 | 22 | 0.130 |
Why?
|
| Dogs | 2 | 2019 | 490 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2017 | 333 | 0.120 |
Why?
|
| Cell Proliferation | 2 | 2016 | 1174 | 0.120 |
Why?
|
| High-Throughput Screening Assays | 1 | 2015 | 48 | 0.120 |
Why?
|
| Students | 1 | 2017 | 233 | 0.120 |
Why?
|
| Diclofenac | 2 | 2011 | 11 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 261 | 0.120 |
Why?
|
| Protein Subunits | 2 | 2013 | 99 | 0.120 |
Why?
|
| Ibuprofen | 2 | 2011 | 30 | 0.120 |
Why?
|
| Female | 7 | 2022 | 38074 | 0.120 |
Why?
|
| Disease Susceptibility | 1 | 2015 | 179 | 0.120 |
Why?
|
| Epithelial Cells | 1 | 2016 | 431 | 0.120 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 694 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2019 | 447 | 0.120 |
Why?
|
| Receptors, Purinergic P2X | 1 | 2013 | 2 | 0.110 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2015 | 317 | 0.110 |
Why?
|
| Tissue Culture Techniques | 1 | 2013 | 62 | 0.110 |
Why?
|
| Calcium Channel Blockers | 1 | 2014 | 138 | 0.110 |
Why?
|
| Gadolinium | 1 | 2014 | 88 | 0.110 |
Why?
|
| Electrochemical Techniques | 1 | 2013 | 23 | 0.110 |
Why?
|
| Imidazoles | 1 | 2014 | 175 | 0.110 |
Why?
|
| Gene Expression | 1 | 2015 | 770 | 0.110 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2012 | 8 | 0.110 |
Why?
|
| Hypoglycemic Agents | 2 | 2013 | 362 | 0.110 |
Why?
|
| Biosensing Techniques | 1 | 2013 | 51 | 0.110 |
Why?
|
| Cell Line, Transformed | 1 | 2012 | 100 | 0.110 |
Why?
|
| United States | 2 | 2022 | 7367 | 0.100 |
Why?
|
| Neuropeptides | 1 | 2012 | 106 | 0.100 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 2011 | 4 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2014 | 682 | 0.100 |
Why?
|
| Arachidonic Acid | 1 | 2011 | 86 | 0.100 |
Why?
|
| Wiskott-Aldrich Syndrome Protein Family | 1 | 2011 | 4 | 0.100 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2011 | 62 | 0.100 |
Why?
|
| Mutant Proteins | 1 | 2011 | 45 | 0.100 |
Why?
|
| Cell Polarity | 1 | 2011 | 49 | 0.090 |
Why?
|
| Cytoskeleton | 1 | 2011 | 84 | 0.090 |
Why?
|
| Cell Movement | 1 | 2013 | 630 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2019 | 1085 | 0.090 |
Why?
|
| 14-3-3 Proteins | 1 | 2010 | 12 | 0.090 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2010 | 19 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2012 | 597 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 434 | 0.080 |
Why?
|
| GTP-Binding Proteins | 1 | 2010 | 231 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2012 | 718 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 1293 | 0.070 |
Why?
|
| Blotting, Western | 3 | 2016 | 954 | 0.070 |
Why?
|
| Models, Biological | 1 | 2011 | 981 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2021 | 2673 | 0.070 |
Why?
|
| Renin-Angiotensin System | 2 | 2019 | 79 | 0.070 |
Why?
|
| Blood Glucose | 2 | 2019 | 631 | 0.060 |
Why?
|
| Protein Transport | 2 | 2019 | 280 | 0.060 |
Why?
|
| Homozygote | 1 | 2022 | 119 | 0.050 |
Why?
|
| Sequence Deletion | 1 | 2022 | 89 | 0.050 |
Why?
|
| Proteinuria | 1 | 2022 | 136 | 0.050 |
Why?
|
| Diet, Protein-Restricted | 1 | 2021 | 4 | 0.050 |
Why?
|
| Phagocytosis | 1 | 2021 | 65 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2022 | 163 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2022 | 222 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2022 | 240 | 0.050 |
Why?
|
| Peroxides | 1 | 2020 | 23 | 0.050 |
Why?
|
| Biological Transport, Active | 1 | 2020 | 49 | 0.050 |
Why?
|
| Streptozocin | 1 | 2020 | 34 | 0.050 |
Why?
|
| Leukocytes | 1 | 2020 | 99 | 0.050 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 61 | 0.050 |
Why?
|
| Cell Respiration | 1 | 2020 | 47 | 0.040 |
Why?
|
| Mast Cells | 1 | 2020 | 113 | 0.040 |
Why?
|
| Polyuria | 1 | 2019 | 2 | 0.040 |
Why?
|
| In Vitro Techniques | 2 | 2011 | 765 | 0.040 |
Why?
|
| Time Factors | 2 | 2021 | 4655 | 0.040 |
Why?
|
| Hypertrophy | 1 | 2019 | 89 | 0.040 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2019 | 29 | 0.040 |
Why?
|
| Madin Darby Canine Kidney Cells | 1 | 2019 | 22 | 0.040 |
Why?
|
| Organ Size | 1 | 2019 | 242 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 2020 | 258 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2019 | 251 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2019 | 204 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2019 | 371 | 0.040 |
Why?
|
| Rats, Transgenic | 1 | 2018 | 24 | 0.040 |
Why?
|
| Phenotype | 1 | 2021 | 947 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 196 | 0.040 |
Why?
|
| Glomerular Filtration Barrier | 1 | 2017 | 3 | 0.040 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2017 | 23 | 0.040 |
Why?
|
| Zebrafish | 1 | 2019 | 187 | 0.040 |
Why?
|
| Nitroso Compounds | 1 | 2017 | 16 | 0.040 |
Why?
|
| Macrophages | 1 | 2021 | 647 | 0.040 |
Why?
|
| Hydrochlorothiazide | 1 | 2017 | 15 | 0.040 |
Why?
|
| Furosemide | 1 | 2017 | 45 | 0.040 |
Why?
|
| Nitric Oxide Donors | 1 | 2017 | 54 | 0.040 |
Why?
|
| Cysteine Proteases | 1 | 2016 | 4 | 0.040 |
Why?
|
| Cathepsin L | 1 | 2016 | 10 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 597 | 0.040 |
Why?
|
| Electrolytes | 1 | 2016 | 47 | 0.030 |
Why?
|
| Corticosterone | 1 | 2016 | 51 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2016 | 89 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2020 | 738 | 0.030 |
Why?
|
| Protein Binding | 1 | 2019 | 1027 | 0.030 |
Why?
|
| Universities | 1 | 2017 | 191 | 0.030 |
Why?
|
| Epithelial Sodium Channel Blockers | 1 | 2015 | 3 | 0.030 |
Why?
|
| Photons | 1 | 2015 | 32 | 0.030 |
Why?
|
| Epithelium | 1 | 2015 | 172 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2019 | 617 | 0.030 |
Why?
|
| Aquaporin 2 | 1 | 2014 | 4 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2019 | 1664 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 2093 | 0.030 |
Why?
|
| Age Factors | 1 | 2018 | 1864 | 0.030 |
Why?
|
| Absorption | 1 | 2013 | 49 | 0.030 |
Why?
|
| Kidney Medulla | 1 | 2013 | 17 | 0.030 |
Why?
|
| Microelectrodes | 1 | 2013 | 16 | 0.030 |
Why?
|
| Kidney Cortex | 1 | 2013 | 19 | 0.030 |
Why?
|
| Chromones | 1 | 2013 | 33 | 0.030 |
Why?
|
| Purines | 1 | 2013 | 39 | 0.030 |
Why?
|
| Electrophysiological Phenomena | 1 | 2012 | 20 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 1342 | 0.030 |
Why?
|
| Guanine Nucleotide Dissociation Inhibitors | 1 | 2012 | 17 | 0.030 |
Why?
|
| Morpholines | 1 | 2013 | 79 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2013 | 200 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 282 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2013 | 118 | 0.030 |
Why?
|
| Ligands | 1 | 2013 | 317 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 223 | 0.030 |
Why?
|
| Heart Failure | 1 | 2020 | 1180 | 0.020 |
Why?
|
| Equipment Design | 1 | 2013 | 500 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2013 | 239 | 0.020 |
Why?
|
| Wiskott-Aldrich Syndrome Protein | 1 | 2011 | 4 | 0.020 |
Why?
|
| Aminoquinolines | 1 | 2011 | 14 | 0.020 |
Why?
|
| NADPH Oxidases | 1 | 2011 | 80 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2011 | 260 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2011 | 160 | 0.020 |
Why?
|
| Ovary | 1 | 2011 | 99 | 0.020 |
Why?
|
| Genotype | 1 | 2012 | 786 | 0.020 |
Why?
|
| Nedd4 Ubiquitin Protein Ligases | 1 | 2010 | 1 | 0.020 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2010 | 7 | 0.020 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2010 | 6 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 252 | 0.020 |
Why?
|
| Cytochalasin D | 1 | 2010 | 10 | 0.020 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2010 | 20 | 0.020 |
Why?
|
| Colchicine | 1 | 2010 | 48 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 791 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2011 | 178 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2010 | 89 | 0.020 |
Why?
|
| Transfection | 1 | 2011 | 782 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 2800 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 1040 | 0.020 |
Why?
|
| Risk Factors | 1 | 2013 | 5731 | 0.010 |
Why?
|